ML
* ROCKET INTERNET / HELLOFRESH - Rocket sold 12.2mn shares at EUR 12.30........
SKY - Sky says remains on track for full year.........................BAML RSTR
ABB - Good with beat across the board, meaning total orders +6% beat (23.7).+5%
PUBLICIS - Much better than expected with org growth +1.6% v 0.7% cons(57)+2-3%
GEA - CFO to take early retirement from position on executive board (104).+2-3%
WPP - Positive read from Publicis reporting better than exp numbers (1145)+2-3%
PERNOD - Very strong with 9M18 OSG at 6.3% v BAML & cons ests at +5.3% (142)+2%
SULZER - Q1 order intake +12%, which is driven by Pumps orders up +15% (115)+2%
PANALPINA - Q118 EBIT of CHF 24.4m v CHF 26m. Encouraging start to '18 (130)+2%
SCHNEIDER - Strong set of nos, guiding towards top end of '18 range (74.3)..+2%
ACCOR - Strong 1Q RevPAR +5.3% with trends looking good into 2Q & beyond(45)+2%
SOUTH 32 - Inline while higher commod prices inc net cash by $477m (212)..+1-2%
NOVARTIS - Small beat, Q118 EPS $1.28 broadly inline with cons $1.27 (79.6).+1%
ATRESMEDIA - Small positive. Bang inline which will be reassuring today (8).+1%
EDENRED - Looks better in Q1 and sees FY revs +7%, which is +2% better(28.8)+1%
GECINA - Reaffirms its 3-6% '18 recurring net income/ share guidance (142)..u/c
MINERS - Copper +0.33%, Iron Ore fut +0.5% with BHP OZ +2.5%, RIO OZ +2.75%.u/c
RENTOKIL - Q1 org growth 3.2%, inline with Q4 but lower than Q1 2017 (273)..u/c
UNILEVER - 3.4% u/l sales growth is bang inline with co compiled cons (46.2)u/c
NESTLE - Org sales growth +2.8% v +2.6% cons. Real internal growth good (75)u/c
GENERALI - Announced disposal of its Belgian operations for EUR 540m (16.4).u/c
ASHTEAD - Negative read from URI -3% after hours after an inline print(2081)-1%
WEIR - Acquiring ESCO in US for $1.3b & intends to sell Flow Control (2097).-1%
BOVIS - Times reports poor build quality who are 2 star v max 5 star(1180)-1-2%
RPC - BBC reporting a plastic straw and cotton bud ban being proposed (792).-2%
DEBENHAMS - Expects pretax to be at the lower end, is a 7-9% downgrade (21)-10%
ULTRA - UK serious fraud office opened a corruption investigation (1145)-15-20%
Mainfirst:
*NESTLE-Sales 21.26b(21.4),Org Rev 2.8%(2.5),Pricing 0.2%(0.5)......+1%*NOVARTIS-EPS 1.28(1.26),OP 3.34b(3.34),NI 2.98b(2.95),o/l ok.......+1.5%
*ABB-Rev 8.63b(8.43),Net 572m(584),Op Ebita 1.06b(1),o/l ok.........+2%
*MERCK-P&G buys the Consumer Health Bizz €3.4b-paying dwn debt......+2%
*TEMENOS-EPS 40c(37),Rev 171.9m(169),Ebit 36.4m(33.6),o/l inline....+2%
*BIOMERIEUX-Sales 587m(598.3),Submits for FDA clearance Biofire.....-0.5%
*EDENRED-Rev 332m(327),Sees FY Op Ebit +9% & Op Rev +7%,SI 2.8%.....+1%
*ACCOR-Rev 633m(456),RevPar +5.3%,L-F-L Rev +9.5%,SI 3.12%..........+2%
*SOITEC-FY Rev 310.6m(304.2),Electronics Ebitda margin +25%.........+1%
*SCHNEIDER ELEC-Rev 5.80b(5.69),Org Sales Grth top end of range.....+2%
*PERNOD-Q3 Sales 1.98b(1.96),Div payout raised,Pft Grth abt 6%......+1%
*PUBLICIS-Rev 2.28b(2.188),Net Rev Grth +1.6%,Margins ok............+2%
*STRATEC BIO-Sales 209.8m(214.3),Ebit 35.5m(34.2),Margin inline.....-1%
*ZOOPLUS-Sales 323m(314),Confirms 2018 f/c 21%-23% vs Cons 23%......+0.5%
*GAM-AUM CHF162.3b,Net Inflows CHF6bln,good demand for spec prods...+1%
*PANALPINA-Sales 1.41b(1.38),Ebitda 64m(35),NP 17m(18),SI 14.4%.....+0.5%
*HELLOFRESH-ABB via MST,Rocket sells 12.2m shs at €12.3(13.36)......-7%
*UNILEVER-Rev 12.6b(12.95),Underlying Sales +3.4%(3.4),B/B of €6b...+1%
Citi
EURO
*Edenred -Q1 rev 332.2 vs est 327m, lfl op ebit growth over 9%. +2%*Novartis -Restricted. rstr
*Arcadis -Confirms rev grwth and improved op margin in '18. +1%
*Nestle -Q1 organic sales grwth 2.8% vs est 2.5%, guidance confirmed. +1%
*Panalpina -Q1 ebit 24.4m vs est 25.7m, profit 16.6m. -1%
*Merck -P&G buy consumer health business for approx $4.2bn. +2%
*ABB -Q1 rev 8.63bn vs est 8.43bn, net 572m vs est 584m. +3%
*Stratec -FY sales 209.8m vs est 215.4m, div 0.80 inline. u/c
*Sulzer -Q1 orders 900.2m, confirms fy guidance. +1%
*Biomerieux -Q1 sales 587m vs est 598.3m. -1%
*Accor -Q1 like-for-like revenue rises 9.5%, revpar rises 5.3%. +2%
*Soitec -FY 310.6m vs est 304.2m, Co. Raises FY ebitda margin outlook. +2%
*Pernod -Organic Sales Growth +9.3% vs consensus +6.1%. Confirms guid. +2%
*Temenos -Sees '18 rev grwth at constant fx 10%-13%. +3%
*Gecina -Q1 lfl rental +1.8%, sees fy net inc rising 3% to 6%. +2%
*Publicis -Q1 rev 2.28bn, net rev grew 1.6% in Q1. +2%
*Hello Fresh-Rocket Internet to place shares in co. -4%
*DNA -Q1 net sales 222.3m vs est 217.7m, ebitda 72.3m vs est 69.2m. +1%*Schneider -Sees organic sales grwth top half of range, reaffirms fy. +2%
*Zooplus -Q1 sales 323m vs est 313.7m, sees fy rev +21% to +23%. +2%
UK
*Ashtead -Q1 TU continued to perform well in Q4,results to be in line u/c*AstraZ -FDA passed Tagrisso for primary endpoint,lung cancer u/c
*BHP Bili -Q3 petroleum output unch,lowers Iron Ore guidance -1%
*Chemring -Contract win,UK ministry of defense £23m +1%
*Debenham -H1 confident of returning to profitable growth,CFO to leave -10%
*Essentra -TS in line so far this year,margin expansion for '18,FD leaving +2%
*Rentokil -Q1 revs £550.7m,adverse FX impact,performance in line u/c
*Sky -Restricted
*Tele Plus-TU sees continued adj ptp £54m,divi 50p +2%
*Unilever -TS Q1 rev e12.6b est e12.95b,buyback e6bn May '18,div e.3872 +1%
*Ultra Elc-SFO opens criminal probe into Algeria ops -5%
*Weir -Placing roughly 7.4%,to buy Esco for $1.29b ?
Numis:
* ASHTEAD MKT Investor event and trading update with FY results in line with expectations.* AVEVA +1-2% Positive FY18 Trading update; Heritage Aveva business delivered 'comfortable double digit' growth
* BELLWAY +2% Numis note out on sector, Bellway preferred pick.
* BLOOMSBURY PUBLISHING MKT Penny Scott-Bayfield will be joining the Board as Group Finance Director
* BOVIS -2% Negative press in The Times today re an investigation into delays/essential repairs on their new builds.
* DISCOVERIE +1% Solid FY trading update with group sales +15% for year.
* ESSENTRA +1% Current trading in line with lfl growth +2%. Confident for FY lfl rev growth and margin expansion.
* GATTACA -10-15% Due to more challenging trading conditions FY PBT expected to be 15% below expectations.
* MOTHERCARE MKT Clive Whiley named Interim Exec Chairman
* REDCENTRIC MKT Trading update in line with expectations
* REDROW +2% Numis note out on sector, Redrow preferred pick.
* RHYTHMONE +2% trading in line and confident of meeting consensus estimates
* SKY MKT Rev’s +5%, business remains on track for full yr
* TEN ENTERTAINMENT +2% Acquires two sites from MFA Bowl for cash consideration of £1.3m. Q1 lfl sales +5.1% which was better than anticipated.
* ULTRA ELECTRONICS -10% SFO Investigation into business in Algeria
* WEIR -5% Buying ESCO for $1.28bn & selling Flow control; placing 16.7m shares. Also announced positive trading update
ShoreCap:
UNILEVER - gd start to year,Q1 sales +3.4%,divi +8%,plans €6bn buyback.......+2%BOVIS - Times front page story of poorly built homes and failures to repair..-1%
BHP BILLITON - reduces iron ore g'dance,on track to achieve 6% volume growth.+1%
ASHTEAD - Investor seminar in NY,perfomed well in Q4msees FY in line........UNCH
AVEVA - FY revs for the enlarged group expected to be in line...............UNCH
RENTOKIL - Q1 rev 550.7m +15.7%.Forex hit pft by 10.15m.sees fy in line......-4%
DEBENHAMS - Confident right plan to return to profitable growth..............-1%
ULTRA ELECTRONICS - Says SFO probe into suspected corruption in Algeria ops..-8%
ASHTEAD - Sees fy results to be in line with forecasts.Performed well in Q4..+2%
RHYTHM ONE - Sees 2019 performance in line with current consensus...........UNCH
SKY - 9m ebitda 1.7m.Says remains on track for FY...........................UNCH
CHEMRING - Uk ministry of defence confirms orders totalling abt 23m..........+1%
ESSENTRA - lfl +2%,in line,CFO leaving.....................................UNCH
WEIR - Buying ESCO for $1.29bn & to sell Flow Control, placing 16.7m shrs....-3%
Jefferies:
** AC FP +1-2% Rev strong, positive outlook comments** ABBN SW +4% 6% beat on orders mainly driven by robotics, earnings good quality
** AHT LN -1-2% Weak read from URI and additional comments from AHT at cap mkt day. FY results expected to be inline with expectations *****
** AVV LN +2% Solid statement, talking strong and solid progress
** DEB LN -10% Cuts divi and expects figs bottom end of range, expect big d/gs. Caveat v v high short interest...
** EDEN FP -1-2% Sales beat but mid term guid looks weak
** NESN SW +1% Org growth beat (2.8% cons 2.6%) driven by volumes +2.6 cons 2% but weak pricing of 0.2% cons 0.5%, a good beat, but lack of pricing upside will raise questions around margins in a rising cmdt price enviroment
** PUB FP +3% Organic growth 1.6% cons 0.5% mostly driven by US
** RI FP +1% Strong organic beat, but partly offset by FX headwinds means no upgrades coming. Guidance raised to top end of range (was 4-6%) will be questioned with org growth so strong as street already at 6.5%. All in all a solid set of numbers with a lot in price
** RTO LN -3% Growth 3.2% cons 4% stating weather and Puerto Rica issues, plus 1% fx headwind
** SU FP +1-2% 1Q Sales beat ests and reits guid. Had good run yesterday
** UNA NA -1% 1Q u/l sales (ex spreads) 3.7% cons 3.8%, Volume +3.6% cons 2.6%, Pricing 0.1% cons 0.4%, Rev €12.6b cons €12.9b. Similar to NESTLE good volume growth with weak pricing, if anything more accute as overall org growth only in line
Berenberg:
ABB +2% Q1 a solid beat on low expectations; slight caution on market share losses ex Robotics & Motion.GAM Hlds +1% Q1 net inflows CHF6bn
MERCK GA +2% Disposal consumer health unit €3.4b, for closing in Q4. Proceeds are mainly to be used for deleveraging. CC 11am UK
NESTLE +1% Q1 slightly ahead - with organic growth +2.8% vs 2.5% cons. Pretty much driven by vol/mix, with pricing just 0.2% (lowest in many yrs). No change to FY guidance
NOVARTIS +1.5% , 1% beat to group sales, EPS in line, guidance confirmed, appointa a new global head of drug development - John Tsai, who has come from Amgen
STRATEC -1% sales were within guidance (€205-220m) at €209.8m (6.1% underlying growth), which was 1% below our est & 2% below cons
SULZER +3% confirms FY guidance
ZOOPLUS +0.5% (scrap) Q1 revs +26% to EUR 323m (313.7m), double -digit growth in all regional markets, confirms FY revs growth of 21-23%.
CS:ABB R Q1 op EBITA $1.06bn, revs 8.63bn
Accor +1-2% Strong Q1 revenue growth, Q1 RevPAR 5.3% CSe 4.1%
Ashtead -1-2% Peer United Rentals -3% on light op profit, CMD today
Aveva M/P Trading expected to be in-line with Board's expectations
BHP Billiton -2-3% O3 production - cuts FY iron ore guidance
Debenhams -10% Numbers inline but guidance and outlook negative
Fraport +1% CS UPGRADE to NEUTRAL (Underperformer vs peers)
Gam -2% IM AUM CHF85.7bn CSe CHF87.0bn, cautious outlook
Generali +1% Selling Belgium business to Athora Holdings for EUR 540m
HSBC +2% CS UPGRADE to NEUTRAL (Risk/reward)
Idorsia M/P Q1 sales CHF7m, op. loss 74m, cash 549m
Merck +2-3% P&G buys consumer health business for EU3.4bn
Miners -1% Copper +0.40%, Brent +1.15%, Iron Ore +1.20%, China +1.50%
Nestle +1% Q1 Organic sales growth 2.8% vs est 2.5%, guidance on track
Norsk Hydro +2-3% Aluminium +4.6% and nickel +2.3% overnight
Novartis +0.5% Q1 EPS $1.28 est $1.26, Q1 net sales $12.69b est $12.43b
Panalpina +1-2% EBIT inline, gross profit CHF370.7m vs cons CHF350m
Pernod +1-2% Q3 sales EU1.98b est EU 1.96b, raises profit forecast
Publicis +1-2% Organic growth +1.6%
Rentokil +2-3% Organic growth 3.2% vs CS ests 2.8%
Schneider +3-4% Org growth +6.2% vs est +3.6
South32 +1% Lifts FY manganese output forecast
Sulzer +2-3% Q1 orders CHF900m vs cons CHF840m, pumps division strong
Ultra Elecs -10% SFO criminal investigation into suspected corruption
Unilever +1% Sales growth inline, outlook inline, confirms buyback
Weir -3-4% Pre-release Q1, announce acquisition, 7.4% share placing
Commerz:
CWC +1.5% Berenberg raises to Buy (Hold) - PT €99 (92)DBK -0.1% COO Kim Hammonds to leave
DLG +0.1% Weak TSMC revenue guidance for Q2
HFG -6.4% RKET placed 12.2mn HelloFresh shares in ABB at €12.30 to 8% discount
LINU +0.1% And Praxair are said to plan more asset sales for merger
MOR -0.3% Announces pricing of ADS in US => equivalent to €80.89, high discount
MRK +2.2% Selling Consumer Health to P&G at good price (€3.4bn)
MTX +0.1% CBK cuts PT to €160 (170) due to FX burden
PSM +0.2% Netflix lifts Europe budget for Originals sharply to $1bn
PUM -0.4% New rated Underperform at RBC - PT €355
RKET -0.1% Placed 12.2mn HelloFresh shares in ABB at €12.30
RRTL -1.0% Netflix lifts Europe budget for Originals sharply to $1bn
SAP -0.1% Peer Temenos with solid Q1 license groiwth
SBS -1.0% FY sales 2% below consensus, EBIT 4% ahead, dividend inline
SIE +0.3% ABB with strong order beat, short-term outlook maintained, pos x-read
Winterflood:
* ACACIA MINING (ACA) -3%; Q1 EPS miss. Gold -45%, primarily due to Bulyanhulu being transitioned to reduced operations in Sept. Q1 rev -33% due to lower sales, offset slightly by higher gold prices. Still awaiting a detailed agreed proposal with regards to Barrick Gold and the Tanzanian government. Production at all 3 of assets was in line with plans and in good position to deliver against FY guidance of 435k-475k ounces.* ASHTEAD (AHT) -1-2%; One liner ahead of investor event to say trading is in line with expectations. URI numbers also out after hours last night, called lower pre-mkt.
* ASTRAZENECA (AZN) +1%; FDA approves Tagrisso for 1st-line use in Non-small cell lung cancer.
* AVEVA GROUP (AVV) M/P; Strong overall trading for the group with revs for enlarged AVEVA Group expected to be in-line with expectations.
* BHP BILLITON (BLT) +2%; Maintains guidance for Petroleum, Metallurgical and energy goal production, however narrows copper and reduces Iron Ore guidance. Will be strong with base metals being higher.
* BOVIS (BVS) -1%; Front page of the Times saying BVS is delaying essential repairs to faulty builds https://www.thetimes.co.uk/edition/news/buyers-in-despair-at-badly-built-new-homes-bovis-cqgpt605j
* DEBENHAMS (DEB) -5%; LFL sales declined 2.2% due to challenging UK market and extreme weather conditions. Disappointing Xmas season saw an increase in competitor discounting which has impacted margins. Divi cut by just over a half to 0.5p. FY 2018 PBT is expected to at the lower end of forecasts. See very challenging market conditions going forward. In addition, CFO to step down.
* ENERGEAN OIL & GAS (ENOG) +1%; Total rev of $57.8m, PBT of $23.7m with cash flow from operating activities $29.1m. Group expects to achieve average production rate of between 4k-5k bopd. Well placed to capitalise on growth plans.
* ESSENTRA (ESNT) +1%; Rev growth of 2% YTD. Strong growth in Components division in all regions which is expected to continue. Outlook remains unch.
* OIL extends gains after stockpile draw yesterday and talk of Trump reinstating sanctions on Iran. MINERS +1.5%, look to build on yesterdays strength as Nickel (+8.5%) and Aluminium (+2.5%) push on. Rusal trades +15% as they discuss deal with China to ease sanctions impact.
* RENTOKIL (RTO) -1%; FY broadly in line, 1Q rev impacted by weather and currency headwinds persist. Guidance remains unch.
* S32 (S32) +2%; Upbeat production report. Sees alumunia prices strengthening for the remainder of the year.
* SKY (SKY) unch; Good overall performance for the quarter. Revs +5%, op prof of £857m, +22%. Outlook remains unch, all about the bid story (note; 21st Century Fox Inc rejected a takeover offer for its entertainment assets from Comcast Corp largely over antitrust concerns and the lack of a breakup fee).
* TELECOM PLUS (TEP) +2-3%; Record rev, profits and divi; record level of switching in energy markets with 20% of switching although TEP churn has been significantly below these levels; Concerns regarding energy market regulation which has seen the stock sell off over 10% in the last week appear over cautious.
* ULTRA ELECTRONICS (ULE) -3%; UK fraud office opened a criminal investigation into their business in Algeria.
* UNILEVER (ULVR) +2%; Sales bang inline. Buyback of €6bn to start in may. Divi small better. Europe weak. America strong. Pretty dull statement all in all but no negative surprises.
* WEIR GROUP (WEIR) -1%; Bullish T/S, with order growth of 22% in Q1 and Minerals orders +13%. Announces the acquisition of ESCO Corporation for $1.29bn, to be funded from existing cash, debt, and via ABB, placing 16.7m shares. Weir also announces intention to sell their Flow Control business. Acquisition will create cost synergies of circa $30m.
********** SMALL CAP **********
* BLOOMSBURY (BMY) unch; Appointment of new FD.
* CHEMRING (CHG) +2%; MOD contracts worth £23m over 2yrs.
* DISCOVER IE (DSCV) +2%; FY T/U in line with record £122m order book. Improved gross margins in H2.
* HIGHLANDS NAT (HNR) +1%; East Denver nat gas purchase agreement - Production from ED wells hits 190k barrels and this agreement offers access to pipeline infrastructure and so paves the way for completion of third party finance for drilling programme, negotiations for which are "well advanced".
* TEN ENTERTAINMENT (TEG) +1-2%; Update, to acquire 2 sites from MFA Bowl for £1.3m. Current trading remains strong. Q1 L4L sales +5.1%.
* TRIFAST (TRI) +3%; Trading update. Overall performed well & FY results slightly ahead of management expectations. Enter new year with confidence. Mindful of macroeconomic challenges. Often buy on rumour sell of fact.
********** AIM **********
* CABOT ENERGY (CAB) +5%; Productions figs doubled in Canada. $10m in cash on balance sheet. Revenues from acquisition expected to be realised in 2018.
* CAMELLIA (CAM) +1%; FY2017 saw improved performance from higher tea prices and optimistic for 2018 with an increased divi.
* ECO ATLANTIC (ECO) +5%; Positive 3D seismic survey completed. Expected to lead to resource upgrade.
* GATTACA (GATC) -20%; Interims in line with Feb warning but expecting a more challenging final quarter and expects FY to be 15% lower than previous expectations.
* HVIVO (HVO) +10%; FY losses reduced to £12.9m, end of year cash @ £20.3m. Focusing on rev growth in airway disease products. CEO Kym Denny to step down with immediate effect.
* IDOX PLC (IDOX) -5%; Mixed update with reorganisation causing disruption but strong sales performance. FY below last year, as expected, with anticipated stronger H2. Digital business has had a number of problems.
* MOTIF BIO (MTFB) +5%; New positive data about its lead drug iclaprim being presented at ECCMID conference.
* MPAC GROUP (MPAC) +1%; AGM and Board change - Trading ahead of last year, in line with expectations. Chairman to stand down for personal reasons. SP has been strong ahead of AGM so we may see some profit taking.
* MYCELX TECH (MYX) +5%; Company is pleased to announce a new purchase order award and equipment sale in Australia which improves the revenue forecast for the year.
* REDCENTRIC (RCN) +1-2%; Trading results inline with expectations. Net Debt £27.7m better than expected.
* RENEURON (RENE) +5%; The company will be lead participant in £1.5m grant to develop cell therapy for retina disease.
* RHYTHMONE PLC (RTHM) +3%; Trading Update. Strong cash flows, larger synergies identified than originally anticipated from YuMe acquistion. Positive outlook for the coming year.
* ROCKHOPPER EXPLORATION (RKH) +3%; No new news in the figures and good progress made over the course of the year in difficult market conditions. 2018 focus remains on securing funding for the 40% owned Sea Lion project.
* SCIENCE GROUP (SAG) +2%; Trading update, Q1 has seen rev and profitability ahead of expectations. Ex div 4.4p today otherwise the movement would have been closer to +5%.
* SHANTA GOLD (SHG) -5%; Underwhelming Q1 production update. Focus remains on deleveraging balance sheet.
* SHEARWATER (SWG) +5%; First contract for recently acquired GeoLang. No mention of revenue but does say will be rolled out to 3,500 end users paying a annual subscription.
* TIZIANA LIFE (TILS) unch; Placed 1m shares at 80p.
* VALIRX (VAL) +25%; Positive results from VAL101, effective in killing cancer cells. Adding commercial partners in the US and China to support manufacture and clinical development.
* XEROS TECH (XSG) -10%; Income increased to £2.3m. EBITDA loss of £28.7m, worse than estimates due a FX impact.
RBC:
*ACACIA MINING: -3% numbers in line, no Tanzania update, stock strong yesterday.*ACCOR: +2% Q1'18 LFL revenues better, RevPar lifted by demand.
*ASHTEAD: +1% expects FY'18 results to be in line with expectations.
*AVEVA: +1% 12-month Pro-Forma revenues in line with forecasts.
*DEBENHAMS: -5% H1 LFL sales -2.2%, CFO leaving, challenging market environment.
*EDENRED: +2% Q1'18 revenues ahead, solid.
*GAM: +1% AUM @ CHF162.3B, net inflows solid, good demand for products.
*GLENCORE: 0% undererperform on possible BUNGE bid.
*MERCK: +2% P&G to buy MRK's consumer unit for $4.2B
*NESTLE: +1% Q1'18 sales touch better, driven by volumes, '20 confirmed.
*NOVARTIS: +2% Q1'18 core EPS ahead, '18 outlook confirmed.
*PANALPINA: -1% Q1'18 EBIT miss, positive summer commentary.
*PERNOD RICARD: +2% Q3'17 sales beat, growing China demand, forecasts raised.
*PUBLICIS: +2% Q1'18 revenues ahead, positive commentary, margin progression.
*RENTOKIL: -2% FY'17 results in line, Q1'18 revenues light, adverse FX impact.
*ROCKHOPPER: +3% '17 production +50%, revenues +40%.
*SCHNEIDER: +2% Q1'18 revenues solid, FY'18 targets confirmed.
*TELECOM PLUS: -2% FY'17 numbers in line, customer growth slowing.
*ULTRA ELECTRONICS: -10% SFO has opened probe into Algeria operations.
*UNILEVER: +1% Q1'18 sales in line, €6B share buyback announced.
*WEIR: -1% to buy ESCO for $1.29B EV.